中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 3
Mar.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(3): 546-551

Value of triglyceride-glucose index combined with obesity index in predicting nonalcoholic fatty liver disease in individuals with obstructive sleep apnea

DOI: 10.3969/j.issn.1001-5256.2023.03.010

  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China

Research funding:

Graduate Student Innovation Fund of Kunming Medical University (2022S073)

More Information
  • Corresponding author: LI Yongxia, yongxiali999@163.com (ORCID: 0000-0002-8166-2211)
  • Received Date: 2022-07-31
  • Accepted Date: 2022-09-23
  • Published Date: 2023-03-20
    Abstract
  •   Objective  To investigate the value of triglyceride-glucose index (TyG), TyG combined with body mass index (BMI), and TyG combined with waist circumference (WC) in predicting nonalcoholic fatty liver disease (NAFLD) in patients with obstructive sleep apnea (OSA).  Methods  A retrospective analysis was performed for 190 patients who underwent sleep respiratory monitoring and were diagnosed with OSA in The Second Affiliated Hospital of Kunming Medical University from January 2020 to December 2021, and according to the results of ultrasonography, they were divided into OSA+NAFLD group with 107 patients and control group with 83 patients. The t-test or the Mann Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The binary logistic regression analysis was used to explore the influencing factors for the development of NAFLD in patients with OSA. The receiver operating characteristic (ROC) curve was plotted for TyG, TyG combined with BMI, and TyG combined with WC in predicting NAFLD in the patients with OSA, and the area under the ROC curve (AUC) was calculated. The Z test was used for comparison of AUC.  Results  Compared with the control group, the OSA+NAFLD group had significantly higher BMI, neck circumference, WC, apnea-hypopnea index, oxygen desaturation index, alanine aminotransferase, gamma-glutamyltransferase, triglyceride, fasting plasma glucose, and TyG and significantly lower age, average SpO2, LSaO2, and high-density lipoprotein cholesterol (all P < 0.05). The binary logistic regression analysis showed that TyG (odds ratio [OR]=1.961, 95% confidence interval [CI]: 1.03-3.73, P=0.04), BMI (OR=1.203, 95%CI: 1.03-1.41, P=0.020), and WC (OR=1.074, 95%CI: 1.01-1.14, P=0.026) were independent risk factors for NAFLD in patients with OSA. TyG, TyG combined with BMI, and TyG combined with WC had an AUC of 0.696 (95%CI: 0.625-0.760), 0.787 (95%CI: 0.722-0.843), and 0.803 (95%CI: 0.739-0.857), respectively, in predicting NAFLD in OSA patients, with an optimal cut-off value of 8.72, 0.36, and 0.60, respectively. TyG combined with BMI had a significantly higher value than TyG in predicting NAFLD in OSA patients (Z=2.542, P=0.011), and TyG combined with WC also had a significantly higher predictive value than TyG (Z=2.976, P=0.002 9).  Conclusion  TyG, TyG combined with BMI, and TyG combined with WC have a good value in predicting NAFLD in OSA patients, among which TyG combined with WC has the best predictive value and is thus expected to become a predictor for the risk of NAFLD in OSA patients.

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    BENJAFIELD AV, AYAS NT, EASTWOOD PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. DOI: 10.1016/S2213-2600(19)30198-5.
    [2]
    YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. DOI: 10.1002/hep.28431.
    [3]
    UMBRO I, FABIANI V, FABIANI M, et al. Association between non-alcoholic fatty liver disease and obstructive sleep apnea[J]. World J Gastroenterol, 2020, 26(20): 2669-2681. DOI: 10.3748/wjg.v26.i20.2669.
    [4]
    KHAN SH, SOBIA F, NIAZI NK, et al. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance[J]. Diabetol Metab Syndr, 2018, 10: 74. DOI: 10.1186/s13098-018-0376-8.
    [5]
    SONG K, LEE HW, CHOI HS, et al. Comparison of the Modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth[J]. Biology (Basel), 2022, 11(5): 685. DOI: 10.3390/biology11050685.
    [6]
    Sleep Medicine Committee of Chinese Medical Doctor Association. Guidelines for multidisciplinary diagnosis and treatment of adult obstructive sleep apnea[J]. Natl Med J China, 2018, 98(24): 1902-1914. DOI: 10.3760/cma.j.issn.0376-2491.2018.24.003.

    中国医师协会睡眠医学专业委员会. 成人阻塞性睡眠呼吸暂停多学科诊疗指南[J]. 中华医学杂志, 2018, 98(24): 1902-1914. DOI: 10.3760/cma.j.issn.0376-2491.2018.24.003.
    [7]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expen Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [8]
    SIMENTAL-MENDÍA LE, RODRÍGUEZ-MORÁN M, GUERRERO-ROMERO F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord, 2008, 6(4): 299-304. DOI: 10.1089/met.2008.0034.
    [9]
    DELONG ER, DELONG DM, CLARKE-PEARSON DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach[J]. Biometrics, 1988, 44(3): 837-845.
    [10]
    MESARWI OA, LOOMBA R, MALHOTRA A. Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease[J]. Am J Respir Crit Care Med, 2019, 199(7): 830-841. DOI: 10.1164/rccm.201806-1109TR.
    [11]
    JIN S, JIANG S, HU A. Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis[J]. Sleep Breath, 2018, 22(3): 841-851. DOI: 10.1007/s11325-018-1625-7.
    [12]
    CHEN LD, ZHANG LJ, LIN XJ, et al. Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea[J]. Eur Arch Otorhinolaryngol, 2018, 275(2): 587-594. DOI: 10.1007/s00405-017-4840-0.
    [13]
    CAKMAK E, DUKSAL F, ALTINKAYA E, et al. Association between the severity of nocturnal hypoxia in obstructive sleep apnea and non-alcoholic fatty liver damage[J]. Hepat Mon, 2015, 15(11): e32655. DOI: 10.5812/hepatmon.32655.
    [14]
    LIU YR, WEN XH, GAO M, et al. Correlation between atherogenic index of plasma and nonalcoholic fatty liver disease in non-obese populations[J]. Clin Misdiagn Misther, 2021, 34(10): 100-104. DOI: 10.3969/j.issn.1002-3429.2021.10.021.

    刘艳如, 温晓华, 高冕, 等. 非肥胖人群血浆致动脉硬化指数与非酒精性脂肪性肝病的相关性[J]. 临床误诊误治, 2021, 34(10): 100-104. DOI: 10.3969/j.issn.1002-3429.2021.10.021.
    [15]
    BETTINI S, SERRA R, FABRIS R, et al. Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study[J]. Eat Weight Disord, 2021, 27(1): 335-343. DOI: 10.1007/s40519-021-01182-9.
    [16]
    FU YM, WANG CY, LI ZB, et al. Diagnostic efficiency of controlled attenuation parameter on hepatic steatosis of patients with nonalcoholic fatty liver disease[J]. Med J Chin PLA, 2022, 47(6): 593-598. DOI: 10.11855/j.issn.0577-7402.2022.06.0593.

    付懿铭, 王春艳, 李忠斌, 等. 受控衰减参数对非酒精性脂肪性肝病患者肝脂肪变性分级的诊断价值[J]. 解放军医学杂志, 2022, 47(6): 593-598. DOI: 10.11855/j.issn.0577-7402.2022.06.0593.
    [17]
    STAREKOVA J, HERNANDO D, PICKHARDT PJ, et al. Quantification of liver fat content with CT and MRI: State of the art[J]. Radiology, 2021, 301(2): 250-262. DOI: 10.1148/radiol.2021204288.
    [18]
    ER LK, WU S, CHOU HH, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals[J]. PLoS One, 2016, 11(3): e0149731. DOI: 10.1371/journal.pone.0149731.
    [19]
    LEE SB, KIM MK, KANG S, et al. Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults[J]. Endocrinol Metab (Seoul), 2019, 34(2): 179-186. DOI: 10.3803/EnM.2019.34.2.179.
    [20]
    KIM HS, CHO YK, KIM EH, et al. Triglyceride glucose-waist circumference is superior to the homeostasis model assessment of insulin resistance in identifying nonalcoholic fatty liver disease in healthy subjects[J]. J Clin Med, 2021, 11(1): 41. DOI: 10.3390/jcm11010041.
    [21]
    KHAMSEH ME, MALEK M, ABBASI R, et al. Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight/obesity[J]. Metab Syndr Relat Disord, 2021, 19(3): 167-173. DOI: 10.1089/met.2020.0109.
    [22]
    FERRAIOLI G, SOARES MONTEIRO LB. Ultrasound-based techniques for the diagnosis of liver steatosis[J]. World J Gastroenterol, 2019, 25(40): 6053-6062. DOI: 10.3748/wjg.v25.i40.6053.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (403) PDF downloads(78) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return